Home

Download

Statistics

Examples

Help

Contact

	Fusion Gene Summary
	Fusion Gene ORF analysis
	Fusion Genomic Features
	Fusion Protein Features
	Fusion Gene Sequence
	Fusion Gene PPI analysis
	Related Drugs
	Related Diseases

Fusion gene:SPINT2-SIPA1L3 (FusionGDB2 ID:85852)

Fusion Gene Summary for SPINT2-SIPA1L3

Fusion gene summary

Fusion gene information	Fusion gene name: SPINT2-SIPA1L3
	Fusion gene ID: 85852
		Hgene	Tgene
	Gene symbol	SPINT2	SIPA1L3
	Gene ID	10653	23094
	Gene name	serine peptidase inhibitor, Kunitz type 2	signal induced proliferation associated 1 like 3
	Synonyms	DIAR3\|HAI-2\|HAI2\|Kop\|PB	CTRCT45\|SPAL3\|SPAR3
	Cytomap	19q13.2	19q13.13-q13.2
	Type of gene	protein-coding	protein-coding
	Description	kunitz-type protease inhibitor 2hepatocyte growth factor activator inhibitor type 2serine protease inhibitor, Kunitz type, 2testicular tissue protein Li 183	signal-induced proliferation-associated 1-like protein 3SIPA1-like protein 3SPA-1-like protein 3spine-associated RapGAP 3
	Modification date	20200315	20200313
	UniProtAcc	.	.
	Ensembl transtripts involved in fusion gene	ENST00000301244, ENST00000587090, ENST00000454580,	ENST00000222345, ENST00000476317,
Fusion gene scores	* DoF score	16 X 8 X 9=1152	30 X 26 X 13=10140
	# samples	21	35
	** MAII score	log2(21/1152*10)=-2.45567948377619 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0	log2(35/10140*10)=-4.85655892005837 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0
Context	PubMed: SPINT2 [Title/Abstract] AND SIPA1L3 [Title/Abstract] AND fusion [Title/Abstract]
Most frequent breakpoint	SPINT2(38774437)-SIPA1L3(38698692), # samples:1 SPINT2(38755638)-SIPA1L3(38689029), # samples:1 SPINT2(38755638)-SIPA1L3(38597177), # samples:1
Anticipated loss of major functional domain due to fusion event.

* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez

Partner	Gene	GO ID	GO term	PubMed ID
Hgene	SPINT2	GO:0022408	negative regulation of cell-cell adhesion	19592578
Hgene	SPINT2	GO:2000146	negative regulation of cell motility	19592578
Tgene	SIPA1L3	GO:0003382	epithelial cell morphogenesis	26231217
Tgene	SIPA1L3	GO:0090162	establishment of epithelial cell polarity	26231217

Fusion gene breakpoints across SPINT2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

Fusion gene breakpoints across SIPA1L3 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.

Source	Disease	Sample	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand
ChimerDB4	LUAD	TCGA-49-AARQ	SPINT2	chr19	38774437	+	SIPA1L3	chr19	38698692	+
ChimerDB4	READ	TCGA-EI-6506	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38689029	+
ChimerDB4	STAD	TCGA-BR-A4PE-01A	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597177	+

Top

Fusion Gene ORF analysis for SPINT2-SIPA1L3

Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.

ORF	Henst	Tenst	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand
5CDS-3UTR	ENST00000301244	ENST00000222345	SPINT2	chr19	38774437	+	SIPA1L3	chr19	38698692	+
5CDS-3UTR	ENST00000587090	ENST00000222345	SPINT2	chr19	38774437	+	SIPA1L3	chr19	38698692	+
5CDS-intron	ENST00000301244	ENST00000476317	SPINT2	chr19	38774437	+	SIPA1L3	chr19	38698692	+
5CDS-intron	ENST00000301244	ENST00000476317	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38689029	+
5CDS-intron	ENST00000301244	ENST00000476317	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597177	+
5CDS-intron	ENST00000454580	ENST00000476317	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38689029	+
5CDS-intron	ENST00000454580	ENST00000476317	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597177	+
5CDS-intron	ENST00000587090	ENST00000476317	SPINT2	chr19	38774437	+	SIPA1L3	chr19	38698692	+
In-frame	ENST00000301244	ENST00000222345	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38689029	+
In-frame	ENST00000301244	ENST00000222345	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597177	+
In-frame	ENST00000454580	ENST00000222345	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38689029	+
In-frame	ENST00000454580	ENST00000222345	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597177	+
intron-3CDS	ENST00000587090	ENST00000222345	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38689029	+
intron-3CDS	ENST00000587090	ENST00000222345	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597177	+
intron-3UTR	ENST00000454580	ENST00000222345	SPINT2	chr19	38774437	+	SIPA1L3	chr19	38698692	+
intron-intron	ENST00000454580	ENST00000476317	SPINT2	chr19	38774437	+	SIPA1L3	chr19	38698692	+
intron-intron	ENST00000587090	ENST00000476317	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38689029	+
intron-intron	ENST00000587090	ENST00000476317	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597177	+

ORFfinder result based on the fusion transcript sequence of in-frame fusion genes.

Henst

Tenst

Hgene

Hchr

Hbp

Hstrand

Tgene

Tchr

Tbp

Tstrand

Seq length
(transcript)

BP loci
(transcript)

Predicted start
(transcript)

Predicted stop
(transcript)

Seq length
(amino acids)

ENST00000301244

SPINT2

chr19

38755638

ENST00000222345

SIPA1L3

chr19

38597177

5990

541

411

3857

1148

ENST00000454580

SPINT2

chr19

38755638

ENST00000222345

SIPA1L3

chr19

38597177

5872

423

293

3739

1148

DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.

Henst	Tenst	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand	No-coding score	Coding score
ENST00000301244	ENST00000222345	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597177	+	0.005764568	0.99423546
ENST00000454580	ENST00000222345	SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597177	+	0.004814578	0.99518543

Top

Fusion Genomic Features for SPINT2-SIPA1L3

FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.

Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand	1-p	p (fusion gene breakpoint)
SPINT2	chr19	38755638	+	SIPA1L3	chr19	38689028	+	7.68E-06	0.9999924
SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597176	+	1.43E-11	1
SPINT2	chr19	38755638	+	SIPA1L3	chr19	38689028	+	7.68E-06	0.9999924
SPINT2	chr19	38755638	+	SIPA1L3	chr19	38597176	+	1.43E-11	1

Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for SPINT2-SIPA1L3

Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:38774437/chr19:38698692)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.

Main function of each fusion partner protein. (from UniProt)

Hgene	Tgene
.	.
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.	FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at
download page

* Minus value of BPloci means that the break pointn is located before the CDS.

- In-frame and retained protein feature among the 13 regional features.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Protein feature

Protein feature note

Tgene

SIPA1L3

chr19:38755638

chr19:38597177

ENST00000222345

1720_1774

676

1782.0

Coiled coil

Ontology_term=ECO:0000255

Tgene

SIPA1L3

chr19:38755638

chr19:38689029

ENST00000222345

1720_1774

1613

1782.0

Coiled coil

Ontology_term=ECO:0000255

Tgene

SIPA1L3

chr19:38755638

chr19:38597177

ENST00000222345

966_1042

676

1782.0

Domain

PDZ

- In-frame and not-retained protein feature among the 13 regional features.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Protein feature

Protein feature note

Hgene

SPINT2

chr19:38755638

chr19:38597177

ENST00000301244

219_252

253.0

Topological domain

Cytoplasmic

Hgene

SPINT2

chr19:38755638

chr19:38597177

ENST00000301244

28_197

253.0

Topological domain

Extracellular

Hgene

SPINT2

chr19:38755638

chr19:38597177

ENST00000454580

219_252

196.0

Topological domain

Cytoplasmic

Hgene

SPINT2

chr19:38755638

chr19:38597177

ENST00000454580

28_197

196.0

Topological domain

Extracellular

Hgene

SPINT2

chr19:38755638

chr19:38689029

ENST00000301244

219_252

253.0

Topological domain

Cytoplasmic

Hgene

SPINT2

chr19:38755638

chr19:38689029

ENST00000301244

28_197

253.0

Topological domain

Extracellular

Hgene

SPINT2

chr19:38755638

chr19:38689029

ENST00000454580

219_252

196.0

Topological domain

Cytoplasmic

Hgene

SPINT2

chr19:38755638

chr19:38689029

ENST00000454580

28_197

196.0

Topological domain

Extracellular

Hgene

SPINT2

chr19:38755638

chr19:38597177

ENST00000301244

198_218

253.0

Transmembrane

Helical

Hgene

SPINT2

chr19:38755638

chr19:38597177

ENST00000454580

198_218

196.0

Transmembrane

Helical

Hgene

SPINT2

chr19:38755638

chr19:38689029

ENST00000301244

198_218

253.0

Transmembrane

Helical

Hgene

SPINT2

chr19:38755638

chr19:38689029

ENST00000454580

198_218

196.0

Transmembrane

Helical

Tgene

SIPA1L3

chr19:38755638

chr19:38597177

ENST00000222345

611_828

676

1782.0

Domain

Rap-GAP

Tgene

SIPA1L3

chr19:38755638

chr19:38689029

ENST00000222345

611_828

1613

1782.0

Domain

Rap-GAP

Tgene

SIPA1L3

chr19:38755638

chr19:38689029

ENST00000222345

966_1042

1613

1782.0

Domain

PDZ

Top

Fusion Gene Sequence for SPINT2-SIPA1L3

For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

>85852_85852_1_SPINT2-SIPA1L3_SPINT2_chr19_38755638_ENST00000301244_SIPA1L3_chr19_38597177_ENST00000222345_length(transcript)=5990nt_BP=541nt
GCGGCCGCGCAGGTGCCTGCCCTTTGCGCCTGCGCCCAGCTCGCCCTGCCTAGCCAGGTGCGCCCCGCCCCCTGCCTGCCCGGCCACCTT
CGGGAGCCGCTTCCAATAGGCGTTCGCCATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCC
GTTGAGTGTCGCAGGCGGCGAGGGCGCGAGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCC
GGAAAGGCGACTTCCGGGGGCTTTGGCACCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGT
TGAGGGGCTTCCCGCACCTGATCGCGAGACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGC
GGGCTGAGGCGGAGCCGGGCGTTTCTCGCCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCAC
GCCGACTCCACGGGAACCCACTCCCTCTACACGATGTACCAGGACTACGAGATCATGTTCCATGTCTCCACCCTGCTCCCTTACACCCCC
AACAACAGGCAGCAGCTGCTACGGAAGAGGCACATAGGAAATGACATCGTGACGATCATCTTCCAGGAGCCTGGCGCGCTACCGTTCACC
CCCAAGAACATCCGCTCCCACTTCCAGCACGTCTTCATCATTGTCCGAGTCCACAACCCCTGCACTGATAACGTCTGTTACAGTATGGCT
GTGACCCGATCCAAAGACGCTCCTCCTTTCGGCCCCCCCATCCCCAGTGGAACCACATTCCGCAAATCCGACGTCTTCAGAGACTTCTTG
CTGGCCAAGGTGATTAACGCTGAGAACGCCGCGCACAAGTCCGACAAGTTCCACACCATGGCCACCAGGACCCGCCAGGAGTATCTCAAG
GACCTGGCCGAAAACTGTGTCTCCAACACCCCCATCGACTCCACCGGCAAATTCAACCTCATCTCCCTGACCTCCAAGAAGAAGGAAAAG
ACAAAAGCACGGGCTGGCGCTGAGCAGCACAGTGCAGGGGCCATCGCCTGGAGGGTGGTGGCCCAGGACTACGCCCAGGGGGTGGAAATC
GACTGCATTTTGGGAATTTCCAATGAGTTTGTGGTGCTCCTGGACTTACGCACCAAGGAGGTGGTGTTCAACTGCTACTGCGGGGATGTC
ATTGGCTGGACTCCAGACTCCTCCACACTCAAAATCTTCTATGGACGAGGAGACCACATCTTCCTACAGGCGACAGAGGGTTCTGTGGAG
GACATAAGGGAGATAGTGCAGAGACTGAAGGTGATGACCAGTGGCTGGGAGACGGTGGACATGACGCTTCGGCGGAACGGGCTCGGGCAG
CTGGGCTTCCACGTGAAGTACGACGGCACGGTGGCCGAGGTTGAGGACTATGGGTTCGCCTGGCAGGCCGGCCTCCGGCAGGGCAGCCGA
CTAGTGGAGATCTGCAAGGTGGCCGTGGTCACACTGACCCACGACCAGATGATCGACCTGCTGCGCACCTCTGTCACTGTGAAGGTGGTC
ATCATCCCGCCTTTTGAGGACGGCACTCCCCGGAGGGGTTGGCCGGAGACCTACGACATGAATACCTCGGAGCCCAAGACGGAGCAGGAA
AGCATCACTCCTGGGGGCCGGCCCCCCTACCGCAGCAATGCTCCCTGGCAGTGGAGCGGGCCCGCATCCCATAACTCTCTACCAGCCTCC
AAGTGGGCCACTCCAACCACTCCCGGCCATGCCCAGTCCCTGAGCCGGCCCCTGAAGCAGACCCCCATAGTCCCCTTCCGGGAGTCCCAG
CCACTGCACAGCAAGAGGCCTGTCAGCTTCCCAGAAACCCCTTACACAGTATCACCAGCAGGGGCCGACAGAGTCCCTCCCTACCGACAG
CCTTCTGGGAGCTTCTCCACCCCCGGTTCGGCCACCTACGTGAGATACAAGCCATCCCCAGAAAGGTACACGGCTGCCCCACACCCCCTG
CTATCTCTTGATCCCCACTTCAGCCACGATGGGACGTCCAGCGGCGACTCCTCTTCCGGCGGCCTGACCAGCCAGGAGAGCACCATGGAA
CGCCAGAAGCCAGAGCCTTTGTGGCATGTGCCTGCCCAGGCCAGGCTCTCAGCCATAGCCGGAAGCAGCGGGAACAAGCACCCGTCCAGG
CAGGATGCAGCAGGCAAAGATTCCCCCAACAGGCATTCCAAAGGAGAACCTCAATACTCAAGTCATTCCAGCAGCAACACCCTCTCCAGC
AACGCATCCAGCAGCCACAGCGACGACCGCTGGTTCGACCCCCTGGACCCCCTGGAGCCAGAGCAAGACCCCCTCTCCAAGGGTGGCTCT
AGTGACAGCGGCATCGACACCACCCTCTACACCTCCAGCCCTAGCTGCATGTCCCTGGCCAAGGCTCCACGGCCCGCCAAGCCACACAAG
CCCCCTGGAAGTATGGGCCTTTGTGGCGGGGGTCGCGAGGCCGCTGGGAGGTCCCACCACGCAGACAGGCGGCGGGAGGTCTCCCCTGCC
CCCGCAGTTGCCGGCCAAAGCAAGGGCTACCGACCGAAGCTGTACTCCTCCGGCTCCAGCACCCCCACGGGACTGGCGGGGGGCAGCCGA
GACCCACCGAGGCAGCCCAGTGACATGGGCTCGAGGGTTGGCTACCCCGCTCAGGTTTACAAAACTGCCAGTGCAGAGACTCCTCGGCCC
TCCCAGCTGGCCCAGCCCAGCCCCTTTCAGCTCTCCGCCTCCGTCCCCAAGTCCTTCTTCTCCAAGCAGCCTGTACGCAATAAGCACCCA
ACAGGGTGGAAGAGAACGGAGGAGCCCCCACCACGGCCACTCCCCTTCAGTGACCCAAAGAAGCAGGTGGACACGAACACCAAAAATGTC
TTTGGGCAACCGAGGTTGAGGGCATCCCTCCGAGACCTCCGGTCACCACGGAAGAACTACAAATCCACCATCGAGGATGACCTGAAGAAA
CTCATCATCATGGACAACCTGGGGCCAGAGCAGGAGAGAGACACGGGACAGTCACCGCAGAAGGGCCTGCAGCGGACGCTGTCGGACGAG
AGCCTGTGCAGCGGGCGCCGGGAGCCCAGCTTCGCCAGCCCCGCTGGCCTAGAGCCAGGGCTGCCCAGCGACGTGCTCTTCACCAGCACC
TGCGCCTTCCCGTCCAGCACGCTGCCTGCACGCCGCCAGCACCAGCACCCCCACCCGCCCGTCGGCCCCGGTGCCACCCCTGCCGCCGGC
AGCGGCTTTCCCGAGAAGAAATCCACCATCTCAGCCTCGGAGCTCTCGCTGGCTGATGGGCGGGACCGCCCCCTGCGGCGCCTGGACCCT
GGGCTGATGCCCCTGCCTGACACAGCTGCTGGCCTCGAGTGGTCCAGCCTGGTGAACGCAGCCAAGGCATACGAAGTGCAAAGAGCCGTC
TCACTCTTCTCTCTGAACGACCCGGCCCTGAGCCCGGACATCCCGCCTGCACACAGTCCTGTCCACAGCCACCTGAGCCTGGAGAGGGGA
CCCCCGACCCCCAGGACCACCCCTACCATGAGCGAGGAGCCACCCCTGGATCTGACAGGCAAGGTGTACCAGCTGGAGGTGATGCTGAAA
CAGCTGCACACTGACCTGCAGAAGGAGAAGCAGGACAAGGTGGTGCTCCAGTCAGAGGTGGCCAGCCTGCGGCAGAACAACCAGCGGCTG
CAGGAGGAGTCGCAGGCCGCCAGCGAGCAGCTGCGCAAGTTTGCGGAGATCTTCTGCAGGGAGAAGAAGGAGCTCTGAGGTGGGAGGCCG
CCGCCCGCCTTCGCTCCTTCCCCTCAGGCCGTGGCCCTGCTGCCTCTCTCCCTCCACTCAGCTCCCAGCTGCCGGTGTGACCAAGATGAC
CCATCCAGGGCCCTCCCCATGGACACGGAAACTCCGATGGCCTCACTAGGGCTGTGAGTCAGGGTCAGCGCGCACAGCCCTCATGCCCCA
GAGGGCGAAGTGGTCTCAGGCCTCCCTCCAAGCTGCCCAGCTGTGGTCCCGGTGAGCTGGGCTGTGCTTACACCGCTCCCGGGCCTGCCC
CGCTGTCCCCATCTAGCCTCTTCCTGGGACCAGCCCTTCGAAGCTGATGGGGACGGAGAGAGGAGCCAGTCTCCAGACGCCTCGGCTCCA
GGAGGTCACACAGCAGGTTTCTGCACCACGCACAACAAAGTTGCGGCTTGTGGGGCCGAGGCCCCTGCATGAAAAGTACAGCGTGAAAGC
AACCCTTTCTTCCCCACACCCAGAGAGGTGAGGCCCGCGTGGACACAGACCAGGGCGCCTCGGTCCCTAGCACGTGAGCTCCAAAAAGCA
CGAACATGATCCCCTCCCTAACCCCCTCCTCCCAAAAAGCAGCCAGGAGCACTTTCTTAGAGTTTAAATTATTTTCTTGGGGGCCTGAGG
ATAGAGAGAGGCAAGGCTAGCCTCCAGAGCCGATTTATTTGAGAGAGAAACTCTATTTGGATCTCCAGGACGGTTTATACGATCTTTTTC
TATCAGCTCCTCTTCCGCCAGAGGCCACTGCACCTGGGCTAGGGGTCCACAGGCCCCTCCACCTTCCAGCTAACCAGGCCAGGCCGGGGC
GGTGGAGCCACCACACAGCCGACTCTCTCCTCCTCCTCCCGGCACGACCTGGCCCTGACCAGCAGCCTCGGCCTCTTCTGGGTTCCAGGA
GGGGCTCCCGAAGCCCTCAGGACAGGGCTGGAGGAGAACAGCCTTCATCTCCTCCTCTGGTTTTTTTTTCCTTTGCAAGTCTCCCAGCCC
ATCTCTCCGAGCAGCGGCCACCAGACCCCCTCACCATGCTCCCCGGGGAGCACTGCACCCCGCGAACCCCACTGGACGCTGGTTCTCTAA
AGGCAATAAGGGGCGGCCATGCCGGTGTGGTACCACGCTGTTCCTCCAGGAAACCGTTTCTTTTTTTCCTTCTTTAAAAGCAAACAGAAA
AAGATATATATATATATATATATATATTTATTTTTTCATGTAGAGTTGGCGCCAGAACAAGCCTGTATGGCCACAGTCTGTGGATTCATC
CCCCCAACCTCAAGCTGAGGACCAAGGCGTGTCCCCTGTGGGCTGGGGGTCAGTGGGAGGACCAGAGGGATGAAGTCAGGGCAGGCCGGT
GCCCTTTTTGGGAGGCACCAGGCGGGGAGGAGTTGGCGGAGCAGGTCTGGCTGTGAGCCAGCACCAGGCAACCCGGCCCTTGTCCAGGGA
CCTCTGCTGCCTTCTCTCTGGGGTCAGGAACCTCAGAGGAGGGGGCTCTGGGGACTGCATAGGACGCAGGCACTCGGAGGTGCCGGTGTG
GATGGGTGGGGGTGAGAGAAGAGGGTTCTTATCGCGTCTCCTGTGATCAGCCTCTGGCCCCCTGGAGGAGGAAACCTCAGCGCTGCCCCT
GCCCCCACCCTCACCCCCAACACCAAGAGTGAGGTGGGCGTGCCCCAGGCAGCGTCCTCAGCCCTGGCCAGCTACTGTGATGCCATCTTC
TCCCCCATCCCCTTCTCTGGGGGGCCCACCCGTCCCCCACCCCCACCCCTTAGACCCTCATCGGGTCCCTTTTTTTTTTTTTTTTTCAGT
TGTCTCCTCCCATCTTCAGATCATTCGAATCATTTTGGGGACTTAATCATGTACATGGACAAGTGTAAATTATGATTTTTGGTTTTGTTT
TCTGTTATTTTTTAAGGATTTCTGCAAAAACAGATCTATTTAATTTGAGGTTGATGTTCTATCCAATGGCCGAAGATAGCAGCAGGTTTT
TTTTTTCATATGTTGATTTGTTTCATTTGGATTTTTTTTTTATTATTCTTTATTGTCTTTTTTTTTTCCCCATCCCTGTCTTGAGATTTT

>85852_85852_1_SPINT2-SIPA1L3_SPINT2_chr19_38755638_ENST00000301244_SIPA1L3_chr19_38597177_ENST00000222345_length(amino acids)=1148AA_BP=43
MRVSAELAMAQLCGLRRSRAFLALLGSLLLSGVLAADRERSIHADSTGTHSLYTMYQDYEIMFHVSTLLPYTPNNRQQLLRKRHIGNDIV
TIIFQEPGALPFTPKNIRSHFQHVFIIVRVHNPCTDNVCYSMAVTRSKDAPPFGPPIPSGTTFRKSDVFRDFLLAKVINAENAAHKSDKF
HTMATRTRQEYLKDLAENCVSNTPIDSTGKFNLISLTSKKKEKTKARAGAEQHSAGAIAWRVVAQDYAQGVEIDCILGISNEFVVLLDLR
TKEVVFNCYCGDVIGWTPDSSTLKIFYGRGDHIFLQATEGSVEDIREIVQRLKVMTSGWETVDMTLRRNGLGQLGFHVKYDGTVAEVEDY
GFAWQAGLRQGSRLVEICKVAVVTLTHDQMIDLLRTSVTVKVVIIPPFEDGTPRRGWPETYDMNTSEPKTEQESITPGGRPPYRSNAPWQ
WSGPASHNSLPASKWATPTTPGHAQSLSRPLKQTPIVPFRESQPLHSKRPVSFPETPYTVSPAGADRVPPYRQPSGSFSTPGSATYVRYK
PSPERYTAAPHPLLSLDPHFSHDGTSSGDSSSGGLTSQESTMERQKPEPLWHVPAQARLSAIAGSSGNKHPSRQDAAGKDSPNRHSKGEP
QYSSHSSSNTLSSNASSSHSDDRWFDPLDPLEPEQDPLSKGGSSDSGIDTTLYTSSPSCMSLAKAPRPAKPHKPPGSMGLCGGGREAAGR
SHHADRRREVSPAPAVAGQSKGYRPKLYSSGSSTPTGLAGGSRDPPRQPSDMGSRVGYPAQVYKTASAETPRPSQLAQPSPFQLSASVPK
SFFSKQPVRNKHPTGWKRTEEPPPRPLPFSDPKKQVDTNTKNVFGQPRLRASLRDLRSPRKNYKSTIEDDLKKLIIMDNLGPEQERDTGQ
SPQKGLQRTLSDESLCSGRREPSFASPAGLEPGLPSDVLFTSTCAFPSSTLPARRQHQHPHPPVGPGATPAAGSGFPEKKSTISASELSL
ADGRDRPLRRLDPGLMPLPDTAAGLEWSSLVNAAKAYEVQRAVSLFSLNDPALSPDIPPAHSPVHSHLSLERGPPTPRTTPTMSEEPPLD

--------------------------------------------------------------
>85852_85852_2_SPINT2-SIPA1L3_SPINT2_chr19_38755638_ENST00000454580_SIPA1L3_chr19_38597177_ENST00000222345_length(transcript)=5872nt_BP=423nt
ATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCCGTTGAGTGTCGCAGGCGGCGAGGGCGCG
AGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCCGGAAAGGCGACTTCCGGGGGCTTTGGCA
CCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGTTGAGGGGCTTCCCGCACCTGATCGCGAG
ACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGCGGGCTGAGGCGGAGCCGGGCGTTTCTCG
CCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCACGCCGACTCCACGGGAACCCACTCCCTCT
ACACGATGTACCAGGACTACGAGATCATGTTCCATGTCTCCACCCTGCTCCCTTACACCCCCAACAACAGGCAGCAGCTGCTACGGAAGA
GGCACATAGGAAATGACATCGTGACGATCATCTTCCAGGAGCCTGGCGCGCTACCGTTCACCCCCAAGAACATCCGCTCCCACTTCCAGC
ACGTCTTCATCATTGTCCGAGTCCACAACCCCTGCACTGATAACGTCTGTTACAGTATGGCTGTGACCCGATCCAAAGACGCTCCTCCTT
TCGGCCCCCCCATCCCCAGTGGAACCACATTCCGCAAATCCGACGTCTTCAGAGACTTCTTGCTGGCCAAGGTGATTAACGCTGAGAACG
CCGCGCACAAGTCCGACAAGTTCCACACCATGGCCACCAGGACCCGCCAGGAGTATCTCAAGGACCTGGCCGAAAACTGTGTCTCCAACA
CCCCCATCGACTCCACCGGCAAATTCAACCTCATCTCCCTGACCTCCAAGAAGAAGGAAAAGACAAAAGCACGGGCTGGCGCTGAGCAGC
ACAGTGCAGGGGCCATCGCCTGGAGGGTGGTGGCCCAGGACTACGCCCAGGGGGTGGAAATCGACTGCATTTTGGGAATTTCCAATGAGT
TTGTGGTGCTCCTGGACTTACGCACCAAGGAGGTGGTGTTCAACTGCTACTGCGGGGATGTCATTGGCTGGACTCCAGACTCCTCCACAC
TCAAAATCTTCTATGGACGAGGAGACCACATCTTCCTACAGGCGACAGAGGGTTCTGTGGAGGACATAAGGGAGATAGTGCAGAGACTGA
AGGTGATGACCAGTGGCTGGGAGACGGTGGACATGACGCTTCGGCGGAACGGGCTCGGGCAGCTGGGCTTCCACGTGAAGTACGACGGCA
CGGTGGCCGAGGTTGAGGACTATGGGTTCGCCTGGCAGGCCGGCCTCCGGCAGGGCAGCCGACTAGTGGAGATCTGCAAGGTGGCCGTGG
TCACACTGACCCACGACCAGATGATCGACCTGCTGCGCACCTCTGTCACTGTGAAGGTGGTCATCATCCCGCCTTTTGAGGACGGCACTC
CCCGGAGGGGTTGGCCGGAGACCTACGACATGAATACCTCGGAGCCCAAGACGGAGCAGGAAAGCATCACTCCTGGGGGCCGGCCCCCCT
ACCGCAGCAATGCTCCCTGGCAGTGGAGCGGGCCCGCATCCCATAACTCTCTACCAGCCTCCAAGTGGGCCACTCCAACCACTCCCGGCC
ATGCCCAGTCCCTGAGCCGGCCCCTGAAGCAGACCCCCATAGTCCCCTTCCGGGAGTCCCAGCCACTGCACAGCAAGAGGCCTGTCAGCT
TCCCAGAAACCCCTTACACAGTATCACCAGCAGGGGCCGACAGAGTCCCTCCCTACCGACAGCCTTCTGGGAGCTTCTCCACCCCCGGTT
CGGCCACCTACGTGAGATACAAGCCATCCCCAGAAAGGTACACGGCTGCCCCACACCCCCTGCTATCTCTTGATCCCCACTTCAGCCACG
ATGGGACGTCCAGCGGCGACTCCTCTTCCGGCGGCCTGACCAGCCAGGAGAGCACCATGGAACGCCAGAAGCCAGAGCCTTTGTGGCATG
TGCCTGCCCAGGCCAGGCTCTCAGCCATAGCCGGAAGCAGCGGGAACAAGCACCCGTCCAGGCAGGATGCAGCAGGCAAAGATTCCCCCA
ACAGGCATTCCAAAGGAGAACCTCAATACTCAAGTCATTCCAGCAGCAACACCCTCTCCAGCAACGCATCCAGCAGCCACAGCGACGACC
GCTGGTTCGACCCCCTGGACCCCCTGGAGCCAGAGCAAGACCCCCTCTCCAAGGGTGGCTCTAGTGACAGCGGCATCGACACCACCCTCT
ACACCTCCAGCCCTAGCTGCATGTCCCTGGCCAAGGCTCCACGGCCCGCCAAGCCACACAAGCCCCCTGGAAGTATGGGCCTTTGTGGCG
GGGGTCGCGAGGCCGCTGGGAGGTCCCACCACGCAGACAGGCGGCGGGAGGTCTCCCCTGCCCCCGCAGTTGCCGGCCAAAGCAAGGGCT
ACCGACCGAAGCTGTACTCCTCCGGCTCCAGCACCCCCACGGGACTGGCGGGGGGCAGCCGAGACCCACCGAGGCAGCCCAGTGACATGG
GCTCGAGGGTTGGCTACCCCGCTCAGGTTTACAAAACTGCCAGTGCAGAGACTCCTCGGCCCTCCCAGCTGGCCCAGCCCAGCCCCTTTC
AGCTCTCCGCCTCCGTCCCCAAGTCCTTCTTCTCCAAGCAGCCTGTACGCAATAAGCACCCAACAGGGTGGAAGAGAACGGAGGAGCCCC
CACCACGGCCACTCCCCTTCAGTGACCCAAAGAAGCAGGTGGACACGAACACCAAAAATGTCTTTGGGCAACCGAGGTTGAGGGCATCCC
TCCGAGACCTCCGGTCACCACGGAAGAACTACAAATCCACCATCGAGGATGACCTGAAGAAACTCATCATCATGGACAACCTGGGGCCAG
AGCAGGAGAGAGACACGGGACAGTCACCGCAGAAGGGCCTGCAGCGGACGCTGTCGGACGAGAGCCTGTGCAGCGGGCGCCGGGAGCCCA
GCTTCGCCAGCCCCGCTGGCCTAGAGCCAGGGCTGCCCAGCGACGTGCTCTTCACCAGCACCTGCGCCTTCCCGTCCAGCACGCTGCCTG
CACGCCGCCAGCACCAGCACCCCCACCCGCCCGTCGGCCCCGGTGCCACCCCTGCCGCCGGCAGCGGCTTTCCCGAGAAGAAATCCACCA
TCTCAGCCTCGGAGCTCTCGCTGGCTGATGGGCGGGACCGCCCCCTGCGGCGCCTGGACCCTGGGCTGATGCCCCTGCCTGACACAGCTG
CTGGCCTCGAGTGGTCCAGCCTGGTGAACGCAGCCAAGGCATACGAAGTGCAAAGAGCCGTCTCACTCTTCTCTCTGAACGACCCGGCCC
TGAGCCCGGACATCCCGCCTGCACACAGTCCTGTCCACAGCCACCTGAGCCTGGAGAGGGGACCCCCGACCCCCAGGACCACCCCTACCA
TGAGCGAGGAGCCACCCCTGGATCTGACAGGCAAGGTGTACCAGCTGGAGGTGATGCTGAAACAGCTGCACACTGACCTGCAGAAGGAGA
AGCAGGACAAGGTGGTGCTCCAGTCAGAGGTGGCCAGCCTGCGGCAGAACAACCAGCGGCTGCAGGAGGAGTCGCAGGCCGCCAGCGAGC
AGCTGCGCAAGTTTGCGGAGATCTTCTGCAGGGAGAAGAAGGAGCTCTGAGGTGGGAGGCCGCCGCCCGCCTTCGCTCCTTCCCCTCAGG
CCGTGGCCCTGCTGCCTCTCTCCCTCCACTCAGCTCCCAGCTGCCGGTGTGACCAAGATGACCCATCCAGGGCCCTCCCCATGGACACGG
AAACTCCGATGGCCTCACTAGGGCTGTGAGTCAGGGTCAGCGCGCACAGCCCTCATGCCCCAGAGGGCGAAGTGGTCTCAGGCCTCCCTC
CAAGCTGCCCAGCTGTGGTCCCGGTGAGCTGGGCTGTGCTTACACCGCTCCCGGGCCTGCCCCGCTGTCCCCATCTAGCCTCTTCCTGGG
ACCAGCCCTTCGAAGCTGATGGGGACGGAGAGAGGAGCCAGTCTCCAGACGCCTCGGCTCCAGGAGGTCACACAGCAGGTTTCTGCACCA
CGCACAACAAAGTTGCGGCTTGTGGGGCCGAGGCCCCTGCATGAAAAGTACAGCGTGAAAGCAACCCTTTCTTCCCCACACCCAGAGAGG
TGAGGCCCGCGTGGACACAGACCAGGGCGCCTCGGTCCCTAGCACGTGAGCTCCAAAAAGCACGAACATGATCCCCTCCCTAACCCCCTC
CTCCCAAAAAGCAGCCAGGAGCACTTTCTTAGAGTTTAAATTATTTTCTTGGGGGCCTGAGGATAGAGAGAGGCAAGGCTAGCCTCCAGA
GCCGATTTATTTGAGAGAGAAACTCTATTTGGATCTCCAGGACGGTTTATACGATCTTTTTCTATCAGCTCCTCTTCCGCCAGAGGCCAC
TGCACCTGGGCTAGGGGTCCACAGGCCCCTCCACCTTCCAGCTAACCAGGCCAGGCCGGGGCGGTGGAGCCACCACACAGCCGACTCTCT
CCTCCTCCTCCCGGCACGACCTGGCCCTGACCAGCAGCCTCGGCCTCTTCTGGGTTCCAGGAGGGGCTCCCGAAGCCCTCAGGACAGGGC
TGGAGGAGAACAGCCTTCATCTCCTCCTCTGGTTTTTTTTTCCTTTGCAAGTCTCCCAGCCCATCTCTCCGAGCAGCGGCCACCAGACCC
CCTCACCATGCTCCCCGGGGAGCACTGCACCCCGCGAACCCCACTGGACGCTGGTTCTCTAAAGGCAATAAGGGGCGGCCATGCCGGTGT
GGTACCACGCTGTTCCTCCAGGAAACCGTTTCTTTTTTTCCTTCTTTAAAAGCAAACAGAAAAAGATATATATATATATATATATATATT
TATTTTTTCATGTAGAGTTGGCGCCAGAACAAGCCTGTATGGCCACAGTCTGTGGATTCATCCCCCCAACCTCAAGCTGAGGACCAAGGC
GTGTCCCCTGTGGGCTGGGGGTCAGTGGGAGGACCAGAGGGATGAAGTCAGGGCAGGCCGGTGCCCTTTTTGGGAGGCACCAGGCGGGGA
GGAGTTGGCGGAGCAGGTCTGGCTGTGAGCCAGCACCAGGCAACCCGGCCCTTGTCCAGGGACCTCTGCTGCCTTCTCTCTGGGGTCAGG
AACCTCAGAGGAGGGGGCTCTGGGGACTGCATAGGACGCAGGCACTCGGAGGTGCCGGTGTGGATGGGTGGGGGTGAGAGAAGAGGGTTC
TTATCGCGTCTCCTGTGATCAGCCTCTGGCCCCCTGGAGGAGGAAACCTCAGCGCTGCCCCTGCCCCCACCCTCACCCCCAACACCAAGA
GTGAGGTGGGCGTGCCCCAGGCAGCGTCCTCAGCCCTGGCCAGCTACTGTGATGCCATCTTCTCCCCCATCCCCTTCTCTGGGGGGCCCA
CCCGTCCCCCACCCCCACCCCTTAGACCCTCATCGGGTCCCTTTTTTTTTTTTTTTTTCAGTTGTCTCCTCCCATCTTCAGATCATTCGA
ATCATTTTGGGGACTTAATCATGTACATGGACAAGTGTAAATTATGATTTTTGGTTTTGTTTTCTGTTATTTTTTAAGGATTTCTGCAAA
AACAGATCTATTTAATTTGAGGTTGATGTTCTATCCAATGGCCGAAGATAGCAGCAGGTTTTTTTTTTCATATGTTGATTTGTTTCATTT
GGATTTTTTTTTTATTATTCTTTATTGTCTTTTTTTTTTCCCCATCCCTGTCTTGAGATTTTCTGGCATGTTTCTGGAGGTTTCAAAGGA

>85852_85852_2_SPINT2-SIPA1L3_SPINT2_chr19_38755638_ENST00000454580_SIPA1L3_chr19_38597177_ENST00000222345_length(amino acids)=1148AA_BP=43
MRVSAELAMAQLCGLRRSRAFLALLGSLLLSGVLAADRERSIHADSTGTHSLYTMYQDYEIMFHVSTLLPYTPNNRQQLLRKRHIGNDIV
TIIFQEPGALPFTPKNIRSHFQHVFIIVRVHNPCTDNVCYSMAVTRSKDAPPFGPPIPSGTTFRKSDVFRDFLLAKVINAENAAHKSDKF
HTMATRTRQEYLKDLAENCVSNTPIDSTGKFNLISLTSKKKEKTKARAGAEQHSAGAIAWRVVAQDYAQGVEIDCILGISNEFVVLLDLR
TKEVVFNCYCGDVIGWTPDSSTLKIFYGRGDHIFLQATEGSVEDIREIVQRLKVMTSGWETVDMTLRRNGLGQLGFHVKYDGTVAEVEDY
GFAWQAGLRQGSRLVEICKVAVVTLTHDQMIDLLRTSVTVKVVIIPPFEDGTPRRGWPETYDMNTSEPKTEQESITPGGRPPYRSNAPWQ
WSGPASHNSLPASKWATPTTPGHAQSLSRPLKQTPIVPFRESQPLHSKRPVSFPETPYTVSPAGADRVPPYRQPSGSFSTPGSATYVRYK
PSPERYTAAPHPLLSLDPHFSHDGTSSGDSSSGGLTSQESTMERQKPEPLWHVPAQARLSAIAGSSGNKHPSRQDAAGKDSPNRHSKGEP
QYSSHSSSNTLSSNASSSHSDDRWFDPLDPLEPEQDPLSKGGSSDSGIDTTLYTSSPSCMSLAKAPRPAKPHKPPGSMGLCGGGREAAGR
SHHADRRREVSPAPAVAGQSKGYRPKLYSSGSSTPTGLAGGSRDPPRQPSDMGSRVGYPAQVYKTASAETPRPSQLAQPSPFQLSASVPK
SFFSKQPVRNKHPTGWKRTEEPPPRPLPFSDPKKQVDTNTKNVFGQPRLRASLRDLRSPRKNYKSTIEDDLKKLIIMDNLGPEQERDTGQ
SPQKGLQRTLSDESLCSGRREPSFASPAGLEPGLPSDVLFTSTCAFPSSTLPARRQHQHPHPPVGPGATPAAGSGFPEKKSTISASELSL
ADGRDRPLRRLDPGLMPLPDTAAGLEWSSLVNAAKAYEVQRAVSLFSLNDPALSPDIPPAHSPVHSHLSLERGPPTPRTTPTMSEEPPLD

--------------------------------------------------------------

Top

Fusion Gene PPI Analysis for SPINT2-SIPA1L3

Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in
ChiPPI page.

Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)

Hgene

Hgene's interactors

Tgene

Tgene's interactors

- Retained PPIs in in-frame fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Still interaction with

- Lost PPIs in in-frame fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Interaction lost with

- Retained PPIs, but lost function due to frame-shift fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Interaction lost with

Top

Related Drugs for SPINT2-SIPA1L3

Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)

Partner

Gene

UniProtAcc

DrugBank ID

Drug name

Drug activity

Drug type

Drug status

Top

Related Diseases for SPINT2-SIPA1L3

Diseases associated with fusion partners.
(DisGeNet 4.0)

Partner

Gene

Disease ID

Disease name

# pubmeds

Source